HYFT (MindWalk Holdings) Margin of Safety % (DCF FCF Based): N/A (As of Jun. 25, 2026)


HYFT MindWalk Holdings Corp HYFT
38 GF Score
Price $1.52
GF Value $0.61
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is MindWalk Holdings Margin of Safety % (DCF FCF Based)?

Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).

Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

MindWalk Holdings's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF FCF Based) is not calculated.

HYFT vs GANX, EXOZ, ANVS: Margin of Safety % (DCF FCF Based) Comparison

For the Biotechnology subindustry, MindWalk Holdings's Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

MindWalk Holdings Margin of Safety % (DCF FCF Based) vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, MindWalk Holdings's Margin of Safety % (DCF FCF Based) distribution charts can be found below:

* The bar in red indicates where MindWalk Holdings's Margin of Safety % (DCF FCF Based) falls into.


HYFT
38GF Score
MindWalk Holdings Corp HYFT
Margin of Safety % (DCF FCF Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is MindWalk Holdings (HYFT) Overvalued in 2026?

Based on GuruFocus' analysis, MindWalk Holdings stock appears to be overvalued. The current stock price of $1.52 is trading 149.2% above its estimated GF Value™ of $0.61. GuruFocus considers MindWalk Holdings to be Significantly Overvalued.

Key valuation signals for HYFT:

  • Margin of Safety % (DCF FCF Based): N/A
  • GF Value™: $0.61 vs. price of $1.52 (149.2% above fair value)
  • GF Score™: 38/100 with 5 warning signs

No single metric tells the full story. See the HYFT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

MindWalk Holdings Business Description

Other Exchanges TQB0:Germany
Address Industrious 823 Congress Avenue, Suite 300, Austin, TX, USA, 78701
MindWalk Holdings Corp is a Bio-Native AI company transforming drug discovery and development. Powered by patented HYFT technology and the LensAI platform, MindWalk unifies sequence, structure, function, and literature into a single computational language and closes the loop with an integrated, full-stack wet lab. The platform supports rapid epitope mapping, de novo molecular design, in silico vaccine exploration, and population-scale biologics analytics that help turn insights into validated candidates at speed.
38GF Score

Get the complete analysis for HYFT

Margin of Safety % (DCF FCF Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.52
Price
$0.61
GF Value